Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Database
Language
Publication year range
1.
Phys Act Nutr ; 26(4): 5-13, 2022 12.
Article in English | MEDLINE | ID: mdl-36775646

ABSTRACT

PURPOSE: Although several physiological roles of lactate have been revealed in the last decades, its effects on energy metabolism and substrate oxidation remain unknown. Therefore, we investigated the effects of lactate on the energy metabolism of resting rats. METHODS: Male rats were divided into control (Con; distilled water), caffeine (Caf; 10 mg/kg), L-lactate (Lac; 2 g/kg), and lactate-plus-caffeine (Lac+Caf; 2 g/ kg + 10 mg) groups. Following oral administration of supplements, resting energy expenditure (study 1), biochemical blood parameters, and mRNA expression involved in energy metabolism in the soleus muscle were measured at different time points within 120 minutes of administration (study 2). Moreover, glycogen level and Pyruvate dehydrogenase (PDH) activity were measured. RESULTS: Groups did not differ in total energy expenditure throughout the 6 hour post-treatment evaluation. Within the first 4 hours, the Lac and Lac+Caf groups showed higher fat oxidation rates than the Con group (p<0.05). Lactate treatment decreased blood free fatty acid levels (p<0.05) and increased the mRNA expression of fatty acid translocase (FAT/CD36) (p<0.05) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) (p<0.05) in the skeletal muscle. Hepatic glycogen level in the Lac+Caf group was significantly increased (p<0.05). Moreover, after 30 and 120 minutes, PDH activity was significantly higher in lactate-supplemented groups compared to Con group (p<0.05). CONCLUSION: Our findings showed that Lac+Caf enhanced fat metabolism in the whole body and skeletal muscle while increasing hepatic glycogen concentration and PDH activity. This indicates Lac+Caf can be used as a potential post-workout supplement.

2.
Phys Act Nutr ; 24(2): 1-5, 2020 Jun 30.
Article in English | MEDLINE | ID: mdl-32698255

ABSTRACT

PURPOSE: Lactate has several beneficial roles as an energy resource and in metabolism. However, studies on the effects of oral administration of lactate on fat metabolism and glycogen synthesis are limited. Therefore, the purpose of the present study was to investigate how oral administration of lactate affects fat metabolism and glycogen synthesis factors at specific times (0, 30, 60, 120 min) after intake. METHODS: Male Sprague Dawley (SD) rats (n = 24) were divided into four groups as follows: the control group (0 min) was sacrificed immediately after oral lactate administration; the test groups were administered lactate (2 g/kg) and sacrificed after 30, 60, and 120 min. Skeletal muscle and liver mRNA expression of GLUT4, FAT/CD36, PDH, CS, PC and GYS2 was assessed using reverse transcription-polymerase chain reaction. RESULTS: GLUT4 and FAT/CD36 expression was significantly increased in skeletal muscle 120 min after lactate administration. PDH expression in skeletal muscle was altered at 30 and 120 min after lactate consumption, but was not significantly different compared to the control. CS, PC and GYS2 expression in liver was increased 60 min after lactate administration. CONCLUSION: Our results indicate that exogenous lactate administration increases GLUT4 and FAT/CD36 expression in the muscle as well as glycogen synthase factors (PC, GYS2) in the liver after 60 min. Therefore, lactate supplementation may increase fat utilization as well as induce positive effects on glycogen synthesis in athletes.

3.
J Appl Physiol (1985) ; 118(6): 742-9, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25571987

ABSTRACT

We examined whether a mixed lactate and caffeine compound (LC) could effectively elicit proliferation and differentiation of satellite cells or activate anabolic signals in skeletal muscles. We cultured C2C12 cells with either lactate or LC for 6 h. We found that lactate significantly increased myogenin and follistatin protein levels and phosphorylation of P70S6K while decreasing the levels of myostatin relative to the control. LC significantly increased protein levels of Pax7, MyoD, and Ki67 in addition to myogenin, relative to control. LC also significantly increased follistatin expression relative to control and stimulated phosphorylation of mTOR and P70S6K. In an in vivo study, male F344/DuCrlCrlj rats were assigned to control (Sed, n = 10), exercise (Ex, n = 12), and LC supplementation (LCEx, n = 13) groups. LC was orally administered daily. The LCEx and Ex groups were exercised on a treadmill, running for 30 min at low intensity every other day for 4 wk. The LCEx group experienced a significant increase in the mass of the gastrocnemius (GA) and tibialis anterior (TA) relative to both the Sed and Ex groups. Furthermore, the LCEx group showed a significant increase in the total DNA content of TA compared with the Sed group. The LCEx group experienced a significant increase in myogenin and follistatin expression of GA relative to the Ex group. These results suggest that administration of LC can effectively increase muscle mass concomitant with elevated numbers of myonuclei, even with low-intensity exercise training, via activated satellite cells and anabolic signals.


Subject(s)
Caffeine/pharmacology , Hypertrophy/drug therapy , Hypertrophy/physiopathology , Lactic Acid/pharmacology , Muscular Diseases/drug therapy , Muscular Diseases/physiopathology , Satellite Cells, Skeletal Muscle/drug effects , Satellite Cells, Skeletal Muscle/physiology , Animals , Cell Differentiation/drug effects , Cell Line , Cell Proliferation/drug effects , Follistatin/metabolism , Hypertrophy/metabolism , Male , Mice , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiopathology , Muscular Diseases/metabolism , MyoD Protein/metabolism , Myogenin/metabolism , Physical Conditioning, Animal/methods , Rats , Rats, Inbred F344 , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Running/physiology , Satellite Cells, Skeletal Muscle/metabolism
4.
Biol Pharm Bull ; 35(7): 1014-21, 2012.
Article in English | MEDLINE | ID: mdl-22791146

ABSTRACT

Lentinula edodes mycelia (L.E.M.) is a dried powder extracted from shiitake mushrooms (Lentinula edodes). We previously demonstrated that it has immunomodulatory effects. In this paper, the direct cytotoxic effects of the polysaccharide-rich fraction of L.E.M. (L.E.M. ethanol precipitate; LEP) on HepG2 human hepatocellular carcinoma (HCC) cells were investigated. LEP directly killed the HepG2 cells efficaciously, but had only minor effects on normal rat hepatocytes and normal mouse dermal cells under the same conditions. Characteristic morphological changes associated with apoptosis such as shrinkage, rounding, and floating as well as chromatin condensation were confirmed; terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining was positive as determined by fluorescence microscopy analyses. The caspase-3 and -8 death receptor pathway was found largely responsible for the apoptotic death of HepG2 cells treated with LEP. In conclusion, LEP can directly induce apoptosis of HepG2 cells, and thus may have potential chemotherapeutic applications for the treatment of HCC.


Subject(s)
Antineoplastic Agents/pharmacology , Complex Mixtures/pharmacology , Mycelium , Shiitake Mushrooms , Animals , Apoptosis/drug effects , Carcinoma, Hepatocellular , Caspase 3/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , DNA Fragmentation , Hep G2 Cells , Hepatocytes/cytology , Hepatocytes/drug effects , Humans , Liver Neoplasms , Mice , Mice, Inbred C57BL , Rats , Rats, Sprague-Dawley , Skin/cytology
5.
J Toxicol Sci ; 35(5): 785-91, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20930474

ABSTRACT

To evaluate the toxicological safety of extract from cultured Lentinula edodes mycelia (L.E.M.), repeated doses (2,000 mg/kg/day) were administered to male and female Wistar rats for 28 days. No mortality or abnormality in the general status or appearance was observed in rats administered L.E.M extract. Body weight and food consumption decreased slightly, particularly in the case of male rats, although the degree of decrease was not as prominent toward the end of administration. Examination of hematology, serum biochemistry, absolute and relative organ weights, autopsy and histopathology revealed only a few statistically significant differences between the treatment and control groups; these differences suggested no clinically significant changes related to toxicity. Consequently, the no observed adverse effect level (NOAEL) of L.E.M. extract was considered to be more than 2,000 mg/kg/day under the conditions of the present study.


Subject(s)
Complex Mixtures/toxicity , Mycelium/chemistry , Shiitake Mushrooms/chemistry , Toxicity Tests, Chronic/methods , Animals , Complex Mixtures/isolation & purification , Female , Male , No-Observed-Adverse-Effect Level , Rats , Rats, Wistar
6.
Biosci Biotechnol Biochem ; 72(4): 1126-9, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18391464

ABSTRACT

Chiisanoside is the main component of Acanthopanax sessiliflorus leaves. Simultaneous administration of chiisanoside resulted in a decrease in the plasma TG level and increase of undigested TG in the intestinal lumen after oil gavage to mice. This suggests that chiisanoside has the potential to prevent obesity as a lipase inhibitor which suppresses fat absorption in vivo.


Subject(s)
Anti-Obesity Agents/pharmacology , Intestine, Small/drug effects , Intestine, Small/metabolism , Oils/metabolism , Oligosaccharides/pharmacology , Triterpenes/pharmacology , Animals , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Intestinal Absorption/drug effects , Male , Mice , Safflower Oil/metabolism , Triglycerides/blood , Triglycerides/metabolism
7.
Fitoterapia ; 79(4): 255-61, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18316163

ABSTRACT

(-) Hydroxycitric acid (HCA), an active ingredient extracted from the Garcinia cambogia fruit rind, has been commonly used as a dietary supplement for weight management. Given the controversy over HCA related testicular toxicity in animal studies, we investigated changes in serum sex hormones levels as an extension of our previous double-blind placebo-controlled trial in human subjects, in which 44 participants received either G. cambogia extract (1667.3 mg/day equivalent to 1000 mg HCA/day) or placebo for 12 weeks. Compared to the placebo group, administration of the extract did not significantly alter the serum testosterone, estrone, and estradiol levels. Similarly, hematology, serum triacylglycerol and serum clinical pathology parameters did not reveal any significant adverse effects. The results of this preliminary investigation indicate that ingestion of G. cambogia extract at dose levels commonly recommended for human use does not affect serum sex hormone levels and blood parameters.


Subject(s)
Garcinia/chemistry , Gonadal Steroid Hormones/blood , Overweight/blood , Plant Extracts/chemistry , Plant Extracts/pharmacology , Adult , Aged , Anti-Obesity Agents/administration & dosage , Anti-Obesity Agents/chemistry , Anti-Obesity Agents/pharmacology , Drug Administration Schedule , Female , Humans , Male , Middle Aged , Plant Extracts/administration & dosage
8.
Curr Ther Res Clin Exp ; 64(8): 551-67, 2003 Sep.
Article in English | MEDLINE | ID: mdl-24944404

ABSTRACT

BACKGROUND: (-)-Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity. OBJECTIVE: The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were body indices (including height, body weight, body mass index [BMI], waist and hip circumference, and waist-hip ratio) and laboratory values (including total cholesterol, triacylglycerol, and free fatty acid). METHODS: This study was performed according to a double-blind, randomized, placebo-controlled, parallel-group design. Subjects aged 20 to 65 years with a visceral fat area >90 cm(2) were enrolled. Subjects were randomly assigned to receive treatment for 12 weeks with G cambogia (containing 1000 mg of HCA per day) or placebo. At the end of the treatment period, both groups were administered placebo for 4 weeks to assess any rebound effect. Each subject underwent a computed tomography scan at the umbilical level at -2, 0, 12, and 16 weeks. RESULTS: Forty-four subjects were randomized at baseline, and 39 completed the study (G cambogia group, n = 18; placebo group, n = 21). At 16 weeks, the G cambogia group had significantly reduced visceral, subcutaneous, and total fat areas compared with the placebo group (all indices P<0.001). No severe adverse effect was observed at any time in the test period. There were no significant differences in BMI or body weight at week 12, but there were slight numeric decreases in body weight and BMI in men. There were no signs of a rebound effect from week 12 to week 16. CONCLUSION: G cambogia reduced abdominal fat accumulation in subjects, regardless of sex, who had the visceral fat accumulation type of obesity. No rebound effect was observed. It is therefore expected that G cambogia may be useful for the prevention and reduction of accumulation of visceral fat.

9.
J Nutr Sci Vitaminol (Tokyo) ; 48(2): 128-33, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12171433

ABSTRACT

(-)-Hydroxycitrate (HCA) is known to inhibit increasing malonyl CoA concentration during endurance exercise. Furthermore, a short-term administration of HCA enhances endurance exercise performance in mice. Therefore we investigated the short-term administration of HCA on the exercise performance of athletes. Subjects were administered 250 mg of HCA or placebo as a control (CON) for 5 d, after each time performing cycle ergometer exercise at 60% VO2max for 60 min followed by 80% VO2max until exhaustion. Blood was collected and expired gas samples analyzed at rest and every 15 min. The respiratory exchange ratio was significantly lower in the HCA trial than in the CON trial (p < 0.05). Fat oxidation was significantly increased by short-term administration of HCA, and carbohydrate oxidation was significantly decreased (p < 0.05) during exercise, presumably resulting in increasing the cycle ergometer exercise time to exhaustion after 1 h of 60% VO2max exercise (p < 0.05). These results suggest that a short-term administration of HCA enhances endurance performance with increasing fat oxidation, which spares glycogen utilization during moderate intensity exercise in athletes.


Subject(s)
Adipose Tissue/metabolism , Citrates/pharmacology , Exercise/physiology , Lipolysis/drug effects , Physical Endurance/drug effects , Adult , Bicycling , Blood Gas Analysis , Citrates/administration & dosage , Exercise Test , Fatty Acids, Nonesterified/blood , Humans , Male , Oxidation-Reduction , Oxygen Consumption/drug effects , Respiration/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL